orphenadrine has been researched along with Facial Pain in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rizzatti-Barbosa, CM | 1 |
| Martinelli, DA | 1 |
| Ambrosano, GM | 1 |
| de Albergaria-Barbosa, JR | 1 |
1 trial available for orphenadrine and Facial Pain
| Article | Year |
|---|---|
Therapeutic response of benzodiazepine, orphenadrine citrate and occlusal splint association in TMD pain.
Topics: Adult; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzodiazepines; Clinical Proto | 2003 |